NewsRelease
ResearchPoster Cites Cleanascite™ for Cancer Cell Metabolism
MONMOUTHJUNCTION, NJ,November2, 2016 -- Biotech Support Group reports on a recent research posterdescribing the simplicity and efficiency of their sample preparationtechnology for clearing lipids from omentalexplant culture system, for the study of ovarian cancer cells andintraperitoneal tumor colonization.
Thecitation is:
Chan,DW, Mak, SL, Ngan, HYS. The significance of lipid metabolism inperitoneal metastases of ovarian cancer. The 2016 Cold Spring HarbourAsia Conference on Cancer and Metabolism, Suzhou, China, 19-23September 2016. http://hub.hku.hk/handle/10722/235385
Inbrief,the authors report thatthe high lipid content in ascetic fluid provides a huge energy sourcefor ovarian cancer cells in peritoneal dissemination andintraperitoneal tumor colonization. In this study, ovarian cancercells co-cultured with an omental explant culture system (OCM) orascetic fluid from ovarian cancer patients exhibited an increase ininvitrocell growth, cell migration/invasion through activation of TAK1/NF-kappaBsignaling cascade. Theabstract states “Incontrast, the oncogenic capacities of ovarian cancer cells wereimpaired when cultured in OCM treated with Cleanascite Lipid RemovalReagent, suggesting that the bioactive lipids in OCM are required forenhanced oncogenic capacities”.
“Iam very pleased that the versatility of Cleanascite™has helped to support a new area of research, studying the metabolicchanges associated with cancer. The exquisite selectivity profile ofCleanascite™makes this possible.” states Swapan Roy, Ph.D., President andFounder of Biotech Support Group.
Formore information visit: Cleanascite™Lipid Removal Reagent and Clarification,at
http://www.biotechsupportgroup.com/Cleanascite-Lipid-Removal-Reagent-p/x2555.htm
AboutBiotech Support Group LLC
Convergingwith cultural and technological disruptions forthcoming inhealthcare, Biotech Support Group develops methods for cost effectiveand efficient sample prep essential for these expanding markets.Following a tiered business strategy, the company continues itsgrowth in the consumable research products area supporting therapidly expanding installation of LC-MS instrument and computationalinfrastructure. For this market, key products include: AlbuVoid™and AlbuSorb™ for albumin depletion, Cleanascite™ for lipidadsorption, HemogloBind™ and HemoVoid™ for hemoglobin removal,and NuGel™ for functional proteomics. From these innovations, thecompany has acquired knowledgebase and biomarker intellectualproperty assets that support discoveries of protein markers fromblood, with special emphasis on early detection and personalizedmedical decisions for cancer patients. For more information, goto http://www.biotechsupportgroup.com
Contact:
Dr. Swapan Roy & Matthew Kuruc
Biotech Support Group LLC
1 Deer Park Drive, Suite M
Monmouth Junction NJ 08852
732-274-2866 Worldwide
800-935-0628 North America
[email protected]
http://www.biotechsupportgroup.com
